Every device must be designed and made so that, when used on a patient in the conditions and for the purposes the manufacturer intends (and, where relevant, by a user with the right knowledge and training), it does not endanger the patient's clinical state or the safety and health of the user or others. Whatever risks remain must be acceptable when weighed against the intended benefit and consistent with a high level of health and safety protection. This principle is the anchor of the benefit and risk determination that the clinical evaluation procedures must demonstrate (regulation 3.11).
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.